Next-Generation AI-Powered Platform for Aquablation® Therapy to Treat Benign Prostatic Hyperplasia (BPH) - Enlarged Prostate

WEST PALM BEACH, Fl – Good Samaritan Medical Center is the first hospital in South Florida outside of Miami to perform Aquablation® therapy with the new HYDROS™ Robotic System, the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.  The procedure was completed by robotic and minimally invasive urologic surgeon Dr. Joshua S. Jue.

“Being the first hospital in our community to offer this procedure keeps us at the forefront of medical technology investment. It gives our patients the best opportunity at a positive outcome,” said Sheri Montgomery, the hospital’s CEO.  “We always put the patient first so they can get back to enjoying a quality lifestyle.”

Aquablation therapy, now delivered by an AI-powered robotic system, is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence across prostates of all shapes and sizes.

BPH is an unfortunate reality of aging for millions of men, which is commonly associated with lower urinary tract symptoms. Common urinary symptoms associated with BPH include frequent daytime urination, waking at night to urinate, straining to urinate, slow urinary stream, sensation of incomplete bladder emptying, and urgency to quickly use the restroom. Without timely treatment, BPH can lead to severe health issues such as permanent bladder or kidney damage, infections, bladder stones, and urinary incontinence. Half of males ages 51-60 have BPH¹ and 99% of men say BPH impacts their quality of life².

quablation therapy was designed to offer a minimally invasive and effective solution for BPH that can be applied to almost all prostate gland sizes. Aquablation therapy is unique in its use of real-time, ultrasound-guided, robotic-assisted waterjet technology, allowing surgeons to create a personalized treatment plan that precisely targets prostate tissue to remove or preserve. With this tailored approach, the system accurately removes obstructing tissue, while protecting apical prostate tissue.

The HYDROS Robotic System represents the next evolution in the delivery of Aquablation therapy. Leveraging insights from over 50,000 procedures, HYDROS features FirstAssist AI™ treatment planning, advanced image guidance, robotic resection, and a streamlined workflow. HYDROS is designed to improve efficiency, enhance surgeon and staff experience, and deliver a more accurate and consistent treatment plan for better clinical outcomes.

Dr. Jue has been performing this operation in Manhattan using the first-generation platform, AquaBeam™ Robotic System, since 2021. At the time of his first operation at Good Samaritan Medical Center, the new HYDROS™ Robotic System was not available in New York City.

“I am proud to offer this new surgical treatment that leverages AI technology to South Florida. Artificial intelligence integration is becoming the future of innovation, and I am happy to see that this technology is becoming integrated into robotic surgery to improve patient outcomes.  Quality healthcare that utilizes the latest technology is available in South Florida at Good Samaritan Medical Center,” said Dr. Jue.

For more information on urological services at Good Samaritan Medical Center, please visit www.palmbeachhealthnetwork.com.